CD274 and neoplasm: Taken together, tumor‐infiltrating TAM are extrinsic regulators of tumor PD‐L1 expression, indicating that combination therapy targeting both tumor PD‐L1 and stromal TAM molecular might be a possible strategy for effective treatment of lung cancer (Fig. 2A).